Analysis of NLR, PLR, and Carcinoembryonic Antigen in Colorectal Cancer Patients
DOI:
https://doi.org/10.24293/ijcpml.v30i2.2063Keywords:
Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, carcinoembryonic antigen, colorectal cancerAbstract
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. The development and prognosis of CRC are affected by the tumor's appearance and the host's inflammatory response. A combination of several parameters, including the Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR), has been used as a cancer prognostic marker. Research needs to be performed to analyze its role in CRC. This study aimed to determine the differences in the NLR, PLR, and CEA values with the severity and site of CRC. Medical record data were collected from 246 CRC patients from January 2021 to June 2022 at Dr. Wahidin Sudirohusodo Hospital were used and grouped by severity (metastatic and non-metastatic) and site (left colon, right colon, rectum). This study collected the data on NLR, PLR, and CEA levels. The Mann-Whitney, Spearman Rho, and Kruskal-Wallis tests were used for statistical analysis by the research objectives (significant if p<0.05). There were differences in median PLR (194.47 vs. 201.18; p=0.045) and CEA (3.3 ng/mL vs. 11.95 ng/mL; p<0.001) between the metastatic and non-metastatic groups, whereas there was no significant difference of median NLR between the two groups (2.77 vs. 2.79; p=0.438). No correlation was found between the NLR, PLR, and CEA level values with the location of CRC (p-values 0.978, 0.511, 0.419, respectively). PLR and CEA values were higher in metastatic CRC than in non-metastatic CRC, while NLR value was not significantly different. There was no correlation between the NLR, PLR, and CEA level values with the CRC site.
Downloads
References
Agusrly C, Sungkar T, Siregar GA. Relationship between staging and carcinoembryonic antigen serum levels in colorectal cancer patients. J Endocrinol Trop Med Infect Dis, 2020; 2(3): 118–23.
Zhang F, Qiao S. Research progress on the relationship between inflammation and colorectal cancer. Ann Gastroenterol Surg, 2022; 6(2): 204–11.
Chan JCY, Chan DL, Diakos CI, Engel A, Pavlakis N, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg, 2017; 265(3): 539–46.
Li X, Guo D, Chu L, Huang Y, Zhang F, et al. Potential diagnostic value of combining inflammatory cell ratios with carcinoembryonic antigen for colorectal cancer. Cancer Manag Res, 2019; 11: 9631–40.
Yamamoto T, Kawada K, Obama K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci, 2021; 22(15): 8002.
Song Y, Yang Y, Gao P, Chen X, Yu D, et al. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer. BMC Cancer, 2017; 17(1): 744.
Tsai P-L, Su W-J, Leung W-H, Lai C-T, Liu C-K. Neutrophil–lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: A systematic review and meta-analysis. J Cancer Res Ther, 2016; 12(2): 582–9.
Ming-Sheng F, Mei-Ling D, Xun-Quan C, Yuan-Xin H, Wei-Jie Z, Qin-Cong P. Preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and cea as the potential prognostic biomarkers for colorectal cancer. Nakamura M, editor. Can J Gastroenterol Hepatol, 2022; 2022: 1–9.
Stojkovic Lalosevic M, Pavlovic Markovic A, Stankovic S, Stojkovic M, Dimitrijevic I, et al. Combined diagnostic efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as biomarkers of systemic inflammation in the diagnosis of colorectal cancer. Dis Markers, 2019; 2019: 1–7.
Temur AA, Rashid FA. Irisin and carcinoembryonic antigen (CEA) as potential diagnostic biomarkers in gastric and colorectal cancers. Reports Biochem Mol Biol, 2021; 10(3): 488–94.
Salem ME, Weinberg BA, Xiu J, El-Deiry WS, Hwang JJ, et al. Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. Oncotarget, 2017; 8(49): 86356–68.
Bhattacharjee D, Quirke P. What is the role of the neutrophil: lymphocyte ratio in colorectal cancer?. Turkish J Color Dis, 2021; 31(1): 1–12.
Xia L, Li W, Zhai J, Yan C, Chen J, Yang H. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer. BMC Cancer, 2020; 20(1): 208.
Paschke S, Jafarov S, Staib L, Kreuser E-D, Maulbecker-Armstrong C, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int J Mol Sci, 2018; 19(9): 2577.
Mazaki J, Katsumata K, Kasahara K, Tago T, Wada T, et al. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: A propensity score analysis. BMC Cancer [Internet], 2020; 20(1): 922.
Liu X-C, Dai Y-L, Huang F, Zhong Z-J, Liu X-F. Diagnostic value of carcinoembryonic antigen combined with multi-inflammatory cell ratios in colorectal cancer. Belardinilli F, editor. Dis Markers, 2022; 2022: 1–6.
Choi WJ, Cleghorn MC, Jiang H, Jackson TD, Okrainec A, Quereshy FA. Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for non-metastatic colorectal cancer. Ann Surg Oncol, 2015; 22(S3): 603–13.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
